THE LONG-TERM SEROLOGICAL PROFILE OF CORONAVAC VACCINE BASED ON COMORBIDITIES AND HISTORY OF SARS-COV-2 INFECTION IN INDONESIA

Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review

(2022) Kin Israel Notarte et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2

(2022) Gatot Soegiarto et al.   VACCINE

Point-of-care test system for detection of immunoglobulin-G and -M against nucleocapsid protein and spike glycoprotein of SARS-CoV-2

(2021) Tao Peng et al.   SENSORS AND ACTUATORS B-CHEMICAL

Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes

(2021) Mayank Batra et al.   Scientific Reports

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

(2021) Nikolaos C. Kyriakidis et al.   npj Vaccines

COVID-19 vaccines

(2021) Duduzile Ndwandwe et al.   CURRENT OPINION IN IMMUNOLOGY

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

(2021) Nawal Al Kaabi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Quantitation of antibodies against SARS‐CoV‐2 spike protein after two doses of CoronaVac in healthcare workers

(2021) Ayşen Bayram et al.   JOURNAL OF MEDICAL VIROLOGY

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

(2021) Alejandro Jara et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

(2021) Moriah Bergwerk et al.   NEW ENGLAND JOURNAL OF MEDICINE

The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation

(2021) Zhihua Bai et al.   Viruses-Basel

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

(2021) Luisa F. Duarte et al.   Frontiers in Immunology

COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers

(2021) Suman Pal et al.   Vaccines

COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study

(2021) Miloslav Klugar et al.   Vaccines

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Development of an inactivated vaccine candidate for SARS-CoV-2

(2020) Qiang Gao et al.   SCIENCE

Biochemical characterization of SARS-CoV-2 nucleocapsid protein

(2020) Weihong Zeng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs

(2020) Jan Van Elslande et al.   CLINICAL MICROBIOLOGY AND INFECTION

Personal Protective Equipment and Mental Health Symptoms Among Nurses During the COVID-19 Pandemic

(2020) Judith E. Arnetz et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study

(2020) Long H Nguyen et al.   Lancet Public Health

Vaccine Against Covid-19 Disease – Present Status of Development

(2020) Ashok Kumar Dutta   INDIAN JOURNAL OF PEDIATRICS

COVID‐19 vaccine research and development: ethical issues

(2020) T. Wibawa   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP)

(2020) Lena Mautner et al.   Virology Journal

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

(2020) Yanjun Zhang et al.   LANCET INFECTIOUS DISEASES

The SARS coronavirus nucleocapsid protein – Forms and functions

(2014) Chung-ke Chang et al.   ANTIVIRAL RESEARCH